Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis

Treatment of Non-Small Cell Lung Cancer

  • Yanfeng Sun Binzhou People’s Hospital
  • Xiaohui Guo
  • Lingling Zhang
  • Wenqian Zhang
  • Yuqin Zuo
Keywords: Brain radiotherapy, targeted therapy, non-small cell lung cancer with brain metastasis, disease control rate

Abstract

Objective: To compare and analyze the clinical efficacy of brain radiotherapy combined with targeted therapy and concurrent radiotherapy and chemotherapy in the treatment of non-small cell lung cancer (NSCLC) with brain metastasis.

Methods: Fifty-eight patients with NSCLC with brain metastasis who were admitted to our hospital between October 2016 and October 2017 were randomly divided into a control group and an observation group, 29 cases in each group. The control group was treated with concurrent radiotherapy and chemotherapy, while the observation group was treated with whole brain radiotherapy plus targeted therapy. The disease control rate, adverse reactions and survival condition were compared between the two groups.

Results: The disease control rate of the observation group was 68.97%, significantly higher than 41.38% of the control group (P<0.05); the total incidence of adverse reactions in the observation group was 6.90%, significantly lower than 24.14% of the control group (P<0.05); the median survival time of the observation group was (16.81±5.32) months, significantly longer than that of the control group ((9.76±3.25) months). The one-year and two-year survival rates in the observation group were significantly higher than those in the control group (P<0.05).

Conclusion: Whole brain radiotherapy combined with targeted therapy is superior to concurrent radiotherapy and chemotherapy in the treatment of NSCLC with brain metastasis and has high safety. It can effectively prolong the life span of patients and is worth clinical promotion and application.

doi: https://doi.org/10.12669/pjms.36.3.1626

How to cite this:
Sun Y, Guo X, Zhang L, Zhang W, Zuo Y. Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis. Pak J Med Sci. 2020;36(3):322-326.  doi: https://doi.org/10.12669/pjms.36.3.1626

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published
2020-03-03
How to Cite
Sun, Y., Guo, X., Zhang, L., Zhang, W., & Zuo, Y. (2020). Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis. Pakistan Journal of Medical Sciences, 36(3). https://doi.org/10.12669/pjms.36.3.1626
Section
Original Articles